Building National Brand and Product Portfolio
ONE OF THE MOST STRATEGICALLY POSITIONED MSOS
Addressable market is >52% of the US population() with significant upside potential
Columbia Care US Footprint
Columbia Care Addressable Market (2)
Adult Use Anticipated
Medical Only
Adult Use & Medical
Pursuit Activity
State
Population (M) Est 2023 Sales (US$M)
Est 2027 Sales (US$M)
Status
Licenses
California
41.3
4,978.5
$
6,576.5
Florida
22.2
$
2,563.5
$
4,503.3
Both
Medical
Unlimited
Limited
Illinois
12.7
$
2,167.3
$
2,632.7
Both
Limited
Massachusetts
7.0
1,799.3
$
1,878.8
Both
Limited
Colorado
6.3
1,657.1
$
1,833.8
Both
Unlimited
$35B+
Arizona
7.3
1,290.6
1,420.3
Both
Limited
New York
20.1
1,258.7
5,000.0(2)
Both*
Limited
Projected 2027 TAM in
Licensed US
States(2)
Pennsylvania
12.9
$
1,204.9
$
1,931.4
Medical
Limited
New Jersey
9.1
$
1,121.6
$
3,000.0(2)
Both
Limited
Ohio
11.7
$
518.3
$
1,604.0
Medical
Limited
Maryland
6.2
479.9
$
1,311.2
Both*
Limited
Conversion to Medical and Adult-Use Offers Significant Upside
Columbia Care has experienced 3x-4x top-line revenue growth in states that
have already converted from medical-only to medical and adult-use
Adult-use sales launched in New Jersey (April 2022), in New York (January
2023, but MSO participation is pending), and in Maryland (July 2023)
Columbia Care's strategic footprint is well positioned for the anticipated
conversion of additional markets
Utah
Virginia
West Virginia
*Legislation passed, Columbia Care first sales in Adult Use pending
3.3
161.2
298.0
Medical
Limited
8.7
$
121.6
3,000.0(2)
Both*
Limited
1.8
52.2
83.7
Medical
Limited
Washington DC
0.7
$
50.8
$
133.8
Medical
Limited
Delaware
1.0
$
39.8
$
149.2
Medical
Limited
TOTAL
172.3
$
19,465.3
$ 35,356.7
1)
2)
US Census Bureau, Company estimates, Gallup poll, as of Nov 2020
Estimated Sales figures from BDSA Market Forecast as of February 2023, broker research, company estimates
8
Columbia CareView entire presentation